Disclaimer

The content on this website is published by Ind-Swift Group, a leading pharmaceutical organization engaged in the research, development, manufacturing, and global distribution of high-quality pharmaceutical products. The website aims to provide general information about the company, its product categories (Ethical, Generic, Ayurvedic), therapeutic segments, manufacturing capabilities, export presence, and investor updates.

This information is strictly intended for registered medical professionals, healthcare practitioners, business partners, and other stakeholders in the healthcare and pharmaceutical industry. The content on this site — including product descriptions, compositions, images, brochures, and therapeutic classifications — is provided solely for educational and reference purposes, and should not be construed as medical advice, product promotion, or inducement to prescribe or consume any pharmaceutical product.

While we make every effort to ensure the accuracy and currency of the information presented, Ind-Swift Group does not guarantee the completeness, reliability, or applicability of the content for any specific medical or commercial purpose. Pharmaceutical knowledge is subject to continuous evolution due to research advancements, regulatory updates, and market dynamics. As such, we recommend that all users consult relevant prescribing information, medical literature, and qualified healthcare professionals before making any clinical or purchase decisions.

Our Ethical Business Division operates with a strong commitment to scientific integrity, segment-led promotion, and compliance with medical-legal regulations (MLR). Product communication related to prescription medicines is intended for qualified medical practitioners only and does not promote or encourage off-label usage or self-medication. Likewise, our Generic and Ayurvedic portfolios, though compliant with relevant global and traditional standards, are presented with appropriate disclaimers and should be interpreted within their regulatory scope.

The site content may contain references to pharmaceutical products that are not approved or available in all countries. Availability is subject to local regulatory approval, market authorization, and specific country regulations. Ind-Swift Group reserves the right to change, update, or withdraw product information at any time without notice.

Furthermore, our Export Division content is designed for B2B stakeholders — including international distributors, licensing partners, and institutional buyers. Any statements made on our global capabilities are indicative and do not imply a guarantee of commercial or regulatory acceptance in every jurisdiction. Documentation such as dossiers, samples, or COAs will be provided only through direct communication and formal agreements, following applicable compliance checks.

Where applicable, share price updates and investor information are based on data provided by third-party financial platforms. We do not ensure real-time accuracy or performance and encourage investors to verify data from official stock exchanges (NSE, BSE) or consult financial advisors before making investment decisions.

This website may also contain links to third-party websites or embedded tools for convenience. Ind-Swift Group does not assume responsibility for the content, accuracy, or privacy practices of external websites.

By accessing and using this website, users agree to the terms of this disclaimer. It is understood that the interpretation and application of the information presented here lies solely with the registered healthcare professional, business decision-maker, or regulatory authority reviewing it.